Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Electromyographic guidance for Botox administration in chronic pelvic floor pain
2017-000642-22Phase 3Active
- Sponsor
- Jose Alberola-Rubio
- Start
- Apr 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of botulinum toxin type A in chronic prostatitis (CP) and Pelvic floor myalgia (PFM), sponsored by Jose Alberola-Rubio. Primary endpoint: Validation of EMG registration system. Started Apr 2017; status: active.
02
Drugs
botulinum toxin type A
03
Conditions
chronic prostatitis (CP)Pelvic floor myalgia (PFM)
Beyond the preview
Go deeper on 2017-000642-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-000642-22.